Annual report pursuant to Section 13 and 15(d)

Shareholders' Deficit (Tables)

v3.23.1
Shareholders' Deficit (Tables)
12 Months Ended
Dec. 31, 2022
Stockholders' Equity Note [Abstract]
Schedule of activity related to non-vested shares
Number of
Non-Vested
Shares
Weighted
Average
Grant Date
Fair Value
Non-vested, December 31, 2020 23,826,926 $ 0.16
Granted 6,194,767 0.06
Forfeited (700,000 ) (0.07 )
Shares vested (15,051,573 ) (0.14 )
Non-vested, December 31, 2021 14,270,120 0.14
Granted 3,500,000 0.014
Shares vested (800,000 ) (0.037 )
Non-vested, December 31, 2022 16,970,120 $ 0.119

Schedule of stock option activities
Number of
Options
Weighted
Average
Exercise
Price
Weighted
Average
Remaining
Contractual
Term (Years)
Aggregate
Intrinsic
Value
Balance Outstanding, December 31, 2020 8,445,698 $ 0.40
-
-
Exercised
-
-
-
-
Balance Outstanding, December 31, 2021 8,445,698 0.40
-
-
Exercised
-
-
-
-
Balance Outstanding, December 31, 2022 8,445,698 $ 0.40 3.43 $
-
Exercisable, December 31, 2022 8,445,698 $ 0.40 3.43 $
-

Schedule of warrant activities
Number of
Warrants
Weighted
Average
Exercise
Price
Weighted
Average
Remaining
Contractual
Term (Years)
Aggregate
Intrinsic
Value
Balance Outstanding December 31, 2020 2,050,000 $ 0.05 3.66 $ 137,000
Granted 16,500,000 0.05
-
-
Cancelled (1,050,000 ) (0.01 )
-
-
Balance Outstanding December 31, 2021 17,500,000 0.05 4.67
-
Granted 33,000,000 0.025
-
-
Cancelled (16,500,000 ) 0.05
-
-
Balance Outstanding December 31, 2022 34,000,000 $ 0.011 3.73 $
-
Exercisable, December 31, 2022 34,000,000 $ 0.011 3.73 $
-